130 related articles for article (PubMed ID: 26886331)
1. Proton-Coupled Organic Cation Antiporter Contributes to the Hepatic Uptake of Matrine.
Wu C; Sun X; Feng C; Liu X; Wang H; Feng F; Zhang J
J Pharm Sci; 2016 Mar; 105(3):1301-6. PubMed ID: 26886331
[TBL] [Abstract][Full Text] [Related]
2. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
3. Proton-coupled organic cation antiporter-mediated uptake of apomorphine enantiomers in human brain capillary endothelial cell line hCMEC/D3.
Okura T; Higuchi K; Kitamura A; Deguchi Y
Biol Pharm Bull; 2014; 37(2):286-91. PubMed ID: 24257040
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine.
Pan X; Wang L; Gründemann D; Sweet DH
Fitoterapia; 2014 Jan; 92():206-10. PubMed ID: 24291757
[TBL] [Abstract][Full Text] [Related]
5. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
8. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
[TBL] [Abstract][Full Text] [Related]
9. [Research progress of pyrilamine-sensitive H~+/OC antiporter].
Wang XY; Zhang ZR
Yao Xue Xue Bao; 2016 Jun; 51(6):886-91. PubMed ID: 29878742
[TBL] [Abstract][Full Text] [Related]
10. Effects of matrine and oxymatrine on catalytic activity of cytochrome p450s in rats.
Yuan F; Chen J; Wu WJ; Chen SZ; Wang XD; Su Z; Huang M
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):906-13. PubMed ID: 20524938
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy.
Zhang JQ; Li YM; Liu T; He WT; Chen YT; Chen XH; Li X; Zhou WC; Yi JF; Ren ZJ
World J Gastroenterol; 2010 Sep; 16(34):4281-90. PubMed ID: 20818811
[TBL] [Abstract][Full Text] [Related]
12. Pyrilamine-sensitive proton-coupled organic cation (H
Wang X; Qi B; Su H; Li J; Sun X; He Q; Fu Y; Zhang Z
J Control Release; 2017 May; 254():34-43. PubMed ID: 28351667
[TBL] [Abstract][Full Text] [Related]
13. The mystery of the human proton-organic cation antiporter: One transport protein or many?
Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
[TBL] [Abstract][Full Text] [Related]
14. Matrine inhibits proliferation and migration of HepG2 cells by downregulating ERK1/2 signaling pathways.
Yu H; Zhu B; Yang W; Zhang Q; Wang W; Zhai W; Lu L; Zheng Y; Dang Z; Li B; Li C; Liang B; Zhang J; Yu X
J Cancer Res Ther; 2020; 16(2):209-214. PubMed ID: 32474503
[TBL] [Abstract][Full Text] [Related]
15. Memantine transport across the mouse blood-brain barrier is mediated by a cationic influx H+ antiporter.
Mehta DC; Short JL; Nicolazzo JA
Mol Pharm; 2013 Dec; 10(12):4491-8. PubMed ID: 24098999
[TBL] [Abstract][Full Text] [Related]
16. Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells.
Xie SB; He XX; Yao SK
Int J Oncol; 2015 Aug; 47(2):517-26. PubMed ID: 26034977
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the H+/organic cation antiporter in nicotine transport in rat liver.
Tega Y; Akanuma S; Kubo Y; Hosoya K
Drug Metab Dispos; 2015 Jan; 43(1):89-92. PubMed ID: 25352656
[TBL] [Abstract][Full Text] [Related]
18. Involvement of a proton-coupled organic cation antiporter in the blood-brain barrier transport of amantadine.
Suzuki T; Aoyama T; Suzuki N; Kobayashi M; Fukami T; Matsumoto Y; Tomono K
Biopharm Drug Dispos; 2016 Sep; 37(6):323-35. PubMed ID: 27146715
[TBL] [Abstract][Full Text] [Related]
19. Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro.
Qin XG; Hua Z; Shuang W; Wang YH; Cui YD
Pharm Biol; 2010 Mar; 48(3):275-81. PubMed ID: 20645813
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of NF-kappa B activity enhanced apoptosis induced by matrine in hepatocellular carcinoma cells].
Gao H; He S; Tang WX; Wang J
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):914-7. PubMed ID: 18171526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
